|
CDKN2C expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.567760E-04 |
| Normal-vs-Stage3 |
3.52270000000265E-05 |
| Normal-vs-Stage4 |
1.678790E-03 |
| Stage1-vs-Stage2 |
8.064800E-01 |
| Stage1-vs-Stage3 |
1.762820E-03 |
| Stage1-vs-Stage4 |
9.555200E-01 |
| Stage2-vs-Stage3 |
7.051900E-02 |
| Stage2-vs-Stage4 |
8.309600E-01 |
| Stage3-vs-Stage4 |
1.758420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4104273304838E-12 |
| Normal-vs-AfricanAmerican |
3.720400E-03 |
| Normal-vs-Asian |
1.59781999999886E-05 |
| Caucasian-vs-AfricanAmerican |
1.232760E-01 |
| Caucasian-vs-Asian |
2.376400E-02 |
| AfricanAmerican-vs-Asian |
9.220800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07590003572966E-09 |
| Normal-vs-Female |
1.62714286489063E-12 |
| Male-vs-Female |
6.980200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66122671174662E-12 |
| Normal-vs-Age(41-60Yrs) |
1.77530001810311E-09 |
| Normal-vs-Age(61-80Yrs) |
1.58220000001652E-06 |
| Normal-vs-Age(81-100Yrs) |
7.008300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.116800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.578200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.530800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.236600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.759800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.30189999994579E-06 |
| Classical-VS-Follicular |
1.566010E-02 |
| Classical-VS-Other |
9.361200E-01 |
| Classical-VS-Normal |
5.40367750545556E-12 |
| Tall-VS-Follicular |
4.01410000017144E-07 |
| Tall-VS-Other |
1.498310E-02 |
| Tall-VS-Normal |
2.670600E-01 |
| Follicular-VS-Other |
2.370600E-01 |
| Follicular-VS-Normal |
4.25049995200766E-09 |
| Other-VS-Normal |
4.113900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63868918434673E-12 |
| Normal-vs-N1 |
4.300700E-03 |
| N0-vs-N1 |
6.610100E-02 |
|
|
